CClinicalTrials.gg
Not yet recruitingNCT07197411Updated Sep 29, 2025

A Comparative Study of Portable Patch-type Carotid Ultrasound CADFlow and Desktop Ultrasound Machines

An observational study in Device Replacement, sponsored by Xuzhou Medical University Affiliated Suqian Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-29.

Sponsored by Xuzhou Medical University Affiliated Suqian Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 79 Years
Sex
All
01

Study summary

observational study The purpose of this observational study is to clarify the consistency, accuracy, and reproducibility of portable patch carotid ultrasound (CADFlow) compared to desktop ultrasound machines in detecting cardiac output (CO), peak velocity (Vmax), and minimum velocity (Vmin) in healthy volunteers.

Read the detailed description

Parameters including cardiac output (CO), peak carotid artery velocity (Vmax), and minimum velocity (Vmin) were monitored in healthy subjects using a portable patch-type carotid ultrasound device (CADFlow). The subjects were placed in a supine position with the head rotated 30° to the contralateral side and the neck slightly extended. The dual-patch probe was then attached to the sites of the most prominent bilateral carotid artery pulsations. The automatic measurement mode was initiated to record blood flow waveforms for 60 seconds. After 30 minutes, the same subjects underwent reassessment of the aforementioned parameters using a conventional ultrasound system. The distal internal diameters of the bilateral common carotid arteries were measured in two-dimensional mode (mean of three measurements). Using pulsed-wave Doppler with an insonation angle ≤60°, Vmax and Vmin were recorded over three consecutive cardiac cycles. The probe was subsequently switched to a transthoracic cardiac probe for CO measurement at the left ventricular outflow tract (LVOT) (mean of three consecutive measurements). The order in which the subjects were monitored with the two devices was randomized.

02

Conditions studied

  • Device Replacement
03

In context

Lead sponsor

This is the only study on the registry with Xuzhou Medical University Affiliated Suqian Hospital as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Include healthy individuals aged 18 to 79

Inclusion criteria

  • Age between 18 and 79 years; No abnormalities found in physical examination; Signed informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Previous or current cardiovascular or cerebrovascular diseases; Carotid intima-media thickness (IMT) ≥ 1.0 mm or plaque; Arrhythmia; ④ BMI > 35 kg/m²; Pregnancy.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
140 participants (estimated)
Patient registry
No

Groups and cohorts

  • cohort of healthy adults

    Monitoring hemodynamic parameters in healthy subjects using two distinct devices

    Diagnostic Test: Evaluating the Consistency and Accuracy of Two Devices in Monitoring Hemodynamic Parameters · Device: Hemodynamic monitoring

Interventions

  • Diagnostic testEvaluating the Consistency and Accuracy of Two Devices in Monitoring Hemodynamic Parameters

    This portable patch-type carotid ultrasound has not yet been used in clinical settings.

  • DeviceHemodynamic monitoring

    Whether the parameters monitored by portable patch-based ultrasound devices agree with the gold standard has not yet been thoroughly validated

06

What researchers measure

Primary outcomes

  1. Evaluation of Consistency Between Two Devices

    Hemodynamic parameters, including cardiac output (CO), peak carotid artery velocity (Vmax), and minimum velocity (Vmin), were monitored in healthy subjects using both a portable patch-based ultrasound device and a conventional console ultrasound machine. The agreement and accuracy between the two devices were evaluated by comparing the correlation coefficients of the parameters and analyzing the mean bias using Bland-Altman plots

    Time frame: through study completion, an average of six months

07

Study locations

1 site
  • Xuzhou Medical University Affiliated Suqian Hospital
    Suqian, Jiangsu 223800, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07197411
Lead sponsor
Xuzhou Medical University Affiliated Suqian Hospital
Responsible party
Ming, Sun (Xuzhou Medical University Affiliated Suqian Hospital, Xuzhou Medical University Affiliated Suqian Hospital) — Principal investigator
First posted
Sep 29, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Sep 29, 2025

Study contacts

MPH
Contact
zhshqin@outlook.com
86-15051314834

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion